Teosyal Redensity 1 represents a groundbreaking injectable skin hydration solution developed by Teoxane Laboratories in Switzerland. This hyaluronic acid skin booster delivers deep hydration while working to stimulate collagen production and improve skin texture through a unique formulation containing eight amino acids and three antioxidants. Designed for patients seeking to enhance their skin’s appearance without …
Teosyal Redensity 1 represents a groundbreaking injectable skin hydration solution developed by Teoxane Laboratories in Switzerland. This hyaluronic acid skin booster delivers deep hydration while working to stimulate collagen production and improve skin texture through a unique formulation containing eight amino acids and three antioxidants. Designed for patients seeking to enhance their skin’s appearance without traditional dermal filler treatment, the procedure typically requires 30-45 minutes per session. Results manifest gradually, with noticeable improvement in skin texture, elasticity, and overall complexion becoming apparent within two weeks following treatment. Clinical observations demonstrate that patients typically experience immediate plumping effects as the non cross-linked hyaluronic acid restores hydration directly into the skin. Within 3-5 days, enhanced luminosity becomes evident as the formula begins to nourish the skin at deeper levels. Full results manifest approximately two weeks post-treatment, revealing improved skin quality through reduced appearance of fine lines and wrinkles, enhanced radiance, and noticeably smoother surface. The injectable treatment provides natural-looking enhancement rather than dramatic volumization, making it ideal for those seeking subtle rejuvenation. Patients frequently report that dull skin transforms into a more vibrant complexion, with uneven skin tone showing marked improvement. Long-lasting benefits continue developing over subsequent weeks as the formulation works to stimulate collagen and enhance skin renewal processes.
Teoxane Laboratories, based in Geneva, Switzerland, developed this specialized skin booster treatment following extensive research into dermal biology and injectable skin solutions. The company maintains rigorous manufacturing standards, producing pharmaceutical-grade products used across London and internationally by aesthetic practitioners.
The formulation combines non-cross-linked hyaluronic acid with a patented blend of eight essential amino acids (glycine, proline, leucine, valine, lysine, alanine, serine, threonine), three powerful antioxidants (glutathione, vitamin C, vitamin B6), zinc, and lidocaine for comfort during administration. This precise combination creates synergistic effects that go beyond simple hydration to actively rejuvenate aging skin at cellular level. The molecular structure allows for optimal integration into tissue, ensuring the product works harmoniously with natural biological processes.
Unlike traditional dermal filler treatments that add volume through cross-linked gel particles, Redensity 1 functions as a true injectable skin hydration solution. The absence of cross-linking means molecules distribute evenly throughout tissue, providing comprehensive hydration and luminosity without creating localized volume. This characteristic makes it particularly effective for treating areas where conventional fillers would appear unnatural, such as delicate zones around eyes or across the entire facial surface.
Prity choose to offer Redensity 1 because it addresses fundamental skin quality concerns that volumising products cannot resolve. The ability to improve skin hydration and elasticity while simultaneously delivering nutrients makes it invaluable for treating early signs of ageing or maintaining results following more invasive procedures. Administered by a trained medical professional, the treatment provides predictable outcomes with minimal downtime, allowing practitioners to deliver safe and effective results consistently.
The product holds CE marking for European distribution and complies with stringent medical device regulations. Manufacturing facilities operate under ISO 13485 certification, ensuring pharmaceutical-grade quality control. Regular third-party testing verifies product consistency, sterility, and performance characteristics.
When evaluated against Profhilo, another popular injectable skin treatment, Redensity 1 offers more targeted nutrient delivery through its amino acid complex, whereas Profhilo focuses primarily on bio-remodeling through ultra-pure hyaluronic acid. Compared to Restylane Vital or Juvederm Volite, the Teosyal Redensity formulation provides broader nutritional support beyond hydration alone. Seventy Hyal, a Korean alternative, contains similar basic components but lacks the comprehensive antioxidant profile found in this Swiss formulation. For patients seeking to enhance skin quality rather than add volume, these distinctions influence treatment selection significantly.
TEOXANE REDENSITY 1 is an exceptionally versatile product and can be used across multiple areas of the face and body. These injectables work to help cellular stimulation and regeneration to repair the skin’s natural barrier. As aforementioned, TEOXANE REDENSITY 1 is best suited to treat the periorbital area and is indicated for the improvement of periocular wrinkles to help soften the signs of ageing. On the other hand, TEOXANE REDENSITY 1 is best suited to treat the face neck, hands, and chest, helping to rejuvenate and hydrate the injected area. TEOXANE REDENSITY 1 can also be used for scar improvement.
Following completion, cool compresses reduce immediate swelling. Practitioners provide detailed aftercare instructions covering activity restrictions, skincare modifications, and signs requiring medical attention. Patients can expect mild redness resembling light sunburn, which typically resolves within 24-48 hours. The entire procedure requires 30-45 minutes, making it convenient for busy schedules. Recovery involves minimal downtime, with most individuals resuming normal activities immediately.
